Last reviewed · How we verify
Part B Assessing GSK1521498
At a glance
| Generic name | Part B Assessing GSK1521498 |
|---|
| Sponsor | GlaxoSmithKline |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.